O	O	O	0	3	The	The	B-NP	DT	O	2	NMOD	O
O	O	O	4	14	regulation	regulation	I-NP	NN	O	8	SUB	O
O	O	O	15	17	of	of	B-PP	IN	O	2	NMOD	O
O	O	O	18	21	HIV	HIV	B-NP	NN	O	3	PMOD	O
O	O	O	22	24	by	by	B-PP	IN	O	2	NMOD	O
O	O	O	25	33	retinoic	retinoic	B-NP	JJ	O	7	NMOD	O
O	O	O	34	38	acid	acid	I-NP	NN	O	5	PMOD	O
O	O	O	39	49	correlates	correlate	B-VP	VBZ	O	0	ROOT	O
O	O	O	50	54	with	with	B-PP	IN	O	8	VMOD	O
O	O	O	55	63	cellular	cellular	B-NP	JJ	O	11	NMOD	O
O	O	O	64	74	expression	expression	I-NP	NN	O	9	PMOD	O
O	O	O	75	77	of	of	B-PP	IN	O	11	NMOD	O
O	O	O	78	81	the	the	B-NP	DT	O	16	NMOD	O
O	O	O	82	90	retinoic	retinoic	I-NP	JJ	B-protein	16	NMOD	B-protein
O	O	O	91	95	acid	acid	I-NP	NN	I-protein	16	NMOD	I-protein
O	O	O	96	105	receptors	receptor	I-NP	NNS	I-protein	12	PMOD	I-protein
O	O	O	105	106	.	.	O	.	O	8	P	O

O	O	O	108	118	OBJECTIVES	OBJECTIVES	B-NP	NNS	O	0	ROOT	O
O	O	O	118	119	:	:	O	:	O	1	P	O
O	O	O	120	122	To	To	B-VP	TO	O	4	VMOD	O
O	O	O	123	130	analyze	analyze	I-VP	VB	O	1	NMOD	O
O	O	O	131	134	the	the	B-NP	DT	O	6	NMOD	O
O	O	O	135	141	effect	effect	I-NP	NN	O	4	OBJ	O
O	O	O	142	144	of	of	B-PP	IN	O	6	NMOD	O
O	O	O	145	153	retinoic	retinoic	B-NP	JJ	O	9	NMOD	O
O	O	O	154	159	acids	acid	I-NP	NNS	O	7	PMOD	O
O	O	O	160	161	(	(	O	(	O	12	DEP	O
O	O	O	161	163	RA	RA	B-NP	NN	O	12	DEP	O
O	O	O	163	164	)	)	O	)	O	9	NMOD	O
O	O	O	165	167	on	on	B-PP	IN	O	6	NMOD	O
T8	B-Entity	B-Entity	168	171	HIV	HIV	B-NP	NN	O	17	NMOD	O
T8	I-Entity	I-Entity	171	172	-	-	O	HYPH	O	17	NMOD	O
T8	I-Entity	I-Entity	172	173	1	1	B-NP	CD	O	17	NMOD	O
O	O	O	174	184	expression	expression	I-NP	NN	O	13	PMOD	O
O	O	O	185	188	and	and	O	CC	O	4	VMOD	O
O	O	O	189	198	correlate	correlate	B-VP	VB	O	4	VMOD	O
O	O	O	199	203	this	this	B-NP	DT	O	21	NMOD	O
O	O	O	204	210	effect	effect	I-NP	NN	O	19	OBJ	O
O	O	O	211	215	with	with	B-PP	IN	O	19	VMOD	O
O	O	O	216	226	expression	expression	B-NP	NN	O	24	NMOD	O
O	O	O	227	233	levels	level	I-NP	NNS	O	22	PMOD	O
O	O	O	234	236	of	of	B-PP	IN	O	24	NMOD	O
O	O	O	237	239	RA	RA	B-NP	NN	B-protein	27	NMOD	B-protein
O	O	O	240	249	receptors	receptor	I-NP	NNS	I-protein	25	PMOD	I-protein
O	O	O	250	251	(	(	O	(	O	30	DEP	O
O	O	O	251	255	RARs	RAR	B-NP	NNS	B-protein	30	DEP	B-protein
O	O	O	255	256	)	)	O	)	O	27	NMOD	O
O	O	O	257	259	in	in	B-PP	IN	O	19	VMOD	O
O	O	O	260	261	T	T	B-NP	NN	B-cell_line	38	NMOD	B-cell_line
O	O	O	261	262	-	-	I-NP	HYPH	I-cell_line	38	NMOD	I-cell_line
O	O	O	262	270	lymphoid	lymphoid	I-NP	JJ	I-cell_line	38	NMOD	I-cell_line
O	O	O	271	274	and	and	I-NP	CC	I-cell_line	38	NMOD	I-cell_line
O	O	O	275	285	monocytoid	monocytoid	I-NP	JJ	I-cell_line	38	NMOD	I-cell_line
O	O	O	286	290	cell	cell	I-NP	NN	I-cell_line	38	NMOD	I-cell_line
O	O	O	291	296	lines	line	I-NP	NNS	I-cell_line	31	PMOD	I-cell_line
O	O	O	296	297	.	.	O	.	O	4	P	O

O	O	O	298	304	DESIGN	DESIGN	B-NP	NN	O	3	NMOD	O
O	O	O	305	308	AND	AND	I-NP	CC	O	3	NMOD	O
O	O	O	309	316	METHODS	METHODS	I-NP	NNS	O	0	ROOT	O
O	O	O	316	317	:	:	O	:	O	3	P	O
O	O	O	318	321	The	The	B-NP	DT	O	6	NMOD	O
O	O	O	322	328	effect	effect	I-NP	NN	O	41	SUB	O
O	O	O	329	331	of	of	B-PP	IN	O	6	NMOD	O
O	O	O	332	335	all	all	B-NP	DT	O	15	NMOD	O
O	O	O	335	336	-	-	I-NP	HYPH	O	15	NMOD	O
O	O	O	336	341	trans	trans	I-NP	NN	B-protein	15	NMOD	B-protein
O	O	O	342	345	and	and	I-NP	CC	I-protein	15	NMOD	I-protein
O	O	O	346	347	9	9	I-NP	CD	I-protein	15	NMOD	I-protein
O	O	O	347	348	-	-	I-NP	HYPH	O	15	NMOD	O
O	O	O	348	351	cis	cis	I-NP	NN	O	15	NMOD	O
O	O	O	352	354	RA	RA	I-NP	NN	O	7	PMOD	O
O	O	O	355	357	on	on	B-PP	IN	O	6	NMOD	O
O	O	O	358	361	HIV	HIV	B-NP	NN	O	20	NMOD	O
O	O	O	361	362	-	-	B-NP	HYPH	O	20	NMOD	O
O	O	O	362	363	1	1	I-NP	CD	O	20	NMOD	O
O	O	O	364	374	production	production	I-NP	NN	O	16	PMOD	O
O	O	O	375	377	in	in	B-PP	IN	O	20	NMOD	O
O	O	O	378	379	T	T	B-NP	NN	O	40	NMOD	O
O	O	O	379	380	-	-	B-NP	HYPH	O	40	NMOD	O
O	O	O	380	388	lymphoid	lymphoid	I-NP	JJ	O	40	NMOD	O
O	O	O	389	390	(	(	O	(	O	29	DEP	O
O	O	O	390	392	H9	H9	B-NP	NN	O	28	NMOD	O
O	O	O	392	393	,	,	O	,	O	28	P	O
O	O	O	394	397	CEM	CEM	B-NP	NN	B-cell_line	29	DEP	B-cell_line
O	O	O	397	398	)	)	O	)	O	24	NMOD	O
O	O	O	399	402	and	and	O	CC	O	40	NMOD	O
O	O	O	403	413	monocytoid	monocytoid	B-NP	NN	B-cell_line	40	NMOD	B-cell_line
O	O	O	414	415	(	(	O	(	I-cell_line	40	NMOD	I-cell_line
O	O	O	415	419	U937	U937	B-NP	NN	I-cell_line	40	NMOD	I-cell_line
O	O	O	419	420	,	,	O	,	I-cell_line	40	P	I-cell_line
O	O	O	420	423	THP	THP	B-NP	NN	I-cell_line	40	NMOD	I-cell_line
O	O	O	423	424	-	-	O	HYPH	I-cell_line	37	P	I-cell_line
O	O	O	424	425	1	1	O	CD	I-cell_line	40	NMOD	I-cell_line
O	O	O	425	426	)	)	O	)	I-cell_line	40	NMOD	I-cell_line
O	O	O	427	431	cell	cell	B-NP	NN	I-cell_line	40	NMOD	I-cell_line
O	O	O	432	437	lines	line	I-NP	NNS	I-cell_line	21	PMOD	I-cell_line
O	O	O	438	441	was	be	B-VP	VBD	O	3	NMOD	O
O	O	O	442	450	measured	measure	I-VP	VBN	O	41	VC	O
O	O	O	451	457	during	during	B-PP	IN	O	42	VMOD	O
O	O	O	458	463	acute	acute	B-NP	JJ	O	47	NMOD	O
O	O	O	464	467	and	and	I-NP	CC	O	47	NMOD	O
O	O	O	468	475	chronic	chronic	I-NP	JJ	O	47	NMOD	O
O	O	O	476	485	infection	infection	I-NP	NN	O	43	PMOD	O
O	O	O	485	486	.	.	O	.	O	3	P	O

O	O	O	487	490	The	The	B-NP	DT	O	3	NMOD	O
O	O	O	491	501	expression	expression	I-NP	NN	O	3	NMOD	O
O	O	O	502	508	levels	level	I-NP	NNS	O	37	SUB	O
O	O	O	509	511	of	of	B-PP	IN	O	3	NMOD	O
O	O	O	512	517	human	human	B-NP	JJ	B-protein	7	NMOD	B-protein
T1	B-Protein	B-Protein	518	521	RAR	RAR	I-NP	NN	I-protein	7	NMOD	I-protein
T1	I-Protein	I-Protein	522	527	alpha	alpha	I-NP	NN	I-protein	12	NMOD	I-protein
O	O	O	528	529	(	(	O	(	O	12	NMOD	O
T2	B-Protein	B-Protein	529	533	hRAR	hRAR	B-NP	NN	B-protein	10	NMOD	B-protein
T2	I-Protein	I-Protein	534	539	alpha	alpha	I-NP	NN	I-protein	12	NMOD	I-protein
O	O	O	539	540	,	,	O	,	O	12	P	O
O	O	O	541	549	receptor	receptor	B-NP	NN	O	26	NMOD	O
O	O	O	550	553	for	for	B-PP	IN	O	12	NMOD	O
O	O	O	554	557	all	all	B-NP	RB	O	16	AMOD	O
O	O	O	557	558	-	-	I-NP	HYPH	O	14	AMOD	O
O	O	O	558	563	trans	trans	I-NP	JJ	O	17	NMOD	O
O	O	O	564	566	RA	RA	I-NP	NN	O	13	PMOD	O
O	O	O	566	567	)	)	O	)	O	12	NMOD	O
O	O	O	568	571	and	and	O	CC	O	26	NMOD	O
O	O	O	572	575	the	the	B-NP	DT	O	26	NMOD	O
O	O	O	576	581	human	human	I-NP	JJ	B-protein	26	NMOD	B-protein
T3	B-Protein	B-Protein	582	590	retinoid	retinoid	I-NP	NN	I-protein	26	NMOD	I-protein
T3	I-Protein	I-Protein	590	591	-	-	I-NP	HYPH	I-protein	26	NMOD	I-protein
T3	I-Protein	I-Protein	591	592	X	X	I-NP	NN	I-protein	26	NMOD	I-protein
T3	I-Protein	I-Protein	593	601	receptor	receptor	I-NP	NN	I-protein	26	NMOD	I-protein
T3	I-Protein	I-Protein	602	607	alpha	alpha	I-NP	NN	I-protein	4	PMOD	I-protein
O	O	O	608	609	(	(	O	(	O	36	DEP	O
T4	B-Protein	B-Protein	609	613	hRXR	hRXR	B-NP	NN	B-protein	30	NMOD	B-protein
T4	I-Protein	I-Protein	614	619	alpha	alpha	I-NP	NN	I-protein	30	NMOD	I-protein
O	O	O	620	628	receptor	receptor	I-NP	NN	I-protein	36	DEP	I-protein
O	O	O	629	632	for	for	B-PP	IN	O	30	NMOD	O
O	O	O	633	634	9	9	B-NP	CD	O	35	NMOD	O
O	O	O	634	635	-	-	I-NP	HYPH	O	35	NMOD	O
O	O	O	635	638	cis	cis	I-NP	NN	O	35	NMOD	O
O	O	O	639	641	RA	RA	I-NP	NN	O	31	PMOD	O
O	O	O	641	642	)	)	O	)	O	26	NMOD	O
O	O	O	643	647	were	be	B-VP	VBD	O	0	ROOT	O
O	O	O	648	658	determined	determine	I-VP	VBN	O	37	VC	O
O	O	O	659	661	by	by	B-PP	IN	O	38	VMOD	O
O	O	O	662	670	Northern	Northern	B-NP	NN	O	42	NMOD	O
O	O	O	671	675	blot	blot	I-NP	NN	O	42	NMOD	O
O	O	O	676	684	analysis	analysis	I-NP	NN	O	39	PMOD	O
O	O	O	684	685	.	.	O	.	O	37	P	O

O	O	O	686	693	RESULTS	RESULTS	B-NP	NNS	O	0	ROOT	O
O	O	O	693	694	:	:	O	:	O	1	P	O
O	O	O	695	699	Both	Both	O	CC	O	12	VMOD	O
O	O	O	700	703	all	all	B-ADJP	RB	O	5	AMOD	O
O	O	O	703	704	-	-	I-ADJP	HYPH	O	12	VMOD	O
O	O	O	704	709	trans	trans	B-NP	JJ	B-protein	8	NMOD	B-protein
O	O	O	710	713	and	and	I-NP	CC	I-protein	8	AMOD	I-protein
O	O	O	714	715	9	9	I-NP	CD	I-protein	11	NMOD	I-protein
O	O	O	715	716	-	-	I-NP	HYPH	O	11	NMOD	O
O	O	O	716	719	cis	cis	I-NP	NN	O	11	NMOD	O
O	O	O	720	722	RA	RA	I-NP	NN	O	12	SUB	O
O	O	O	723	732	inhibited	inhibit	B-VP	VBD	O	1	NMOD	O
O	O	O	733	738	virus	virus	B-NP	NN	O	14	NMOD	O
O	O	O	739	750	replication	replication	I-NP	NN	O	12	OBJ	O
O	O	O	751	753	in	in	B-PP	IN	O	14	NMOD	O
O	O	O	754	757	HIV	HIV	B-NP	NN	B-cell_line	23	NMOD	B-cell_line
O	O	O	757	758	-	-	B-NP	HYPH	I-cell_line	23	NMOD	I-cell_line
O	O	O	758	759	1	1	I-NP	CD	I-cell_line	23	NMOD	I-cell_line
O	O	O	760	764	IIIB	IIIB	I-NP	NN	I-cell_line	23	NMOD	I-cell_line
O	O	O	764	765	-	-	B-NP	HYPH	I-cell_line	23	NMOD	I-cell_line
O	O	O	765	773	infected	infect	I-NP	VBN	I-cell_line	23	NMOD	I-cell_line
O	O	O	774	784	monocytoid	monocytoid	I-NP	JJ	I-cell_line	23	NMOD	I-cell_line
O	O	O	785	790	cells	cell	I-NP	NNS	I-cell_line	15	PMOD	I-cell_line
O	O	O	790	791	,	,	O	,	O	12	P	O
O	O	O	792	794	in	in	B-PP	IN	O	12	VMOD	O
O	O	O	795	798	the	the	B-NP	DT	O	29	NMOD	O
O	O	O	799	807	presence	presence	I-NP	NN	O	29	NMOD	O
O	O	O	808	811	and	and	I-NP	CC	O	29	NMOD	O
O	O	O	812	819	absence	absence	I-NP	NN	O	25	PMOD	O
O	O	O	820	822	of	of	B-PP	IN	O	29	NMOD	O
O	O	O	823	826	the	the	B-NP	DT	O	38	NMOD	O
O	O	O	827	829	co	co	I-NP	AFX	O	38	NMOD	O
O	O	O	829	830	-	-	I-NP	HYPH	O	38	NMOD	O
O	O	O	830	841	stimulatory	stimulatory	I-NP	JJ	O	38	NMOD	O
O	O	O	842	847	agent	agent	I-NP	NN	O	38	NMOD	O
O	O	O	848	855	phorbol	phorbol	I-NP	NN	O	38	NMOD	O
O	O	O	856	865	myristate	myristate	I-NP	NN	O	38	NMOD	O
O	O	O	866	873	acetate	acetate	I-NP	NN	O	30	PMOD	O
O	O	O	874	875	(	(	O	(	O	41	DEP	O
O	O	O	875	878	PMA	PMA	B-NP	NN	O	41	DEP	O
O	O	O	878	879	)	)	O	)	O	38	NMOD	O
O	O	O	879	880	.	.	O	.	O	1	P	O

O	O	O	881	884	The	The	B-NP	DT	O	2	NMOD	O
O	O	O	885	894	retinoids	retinoid	I-NP	NNS	O	3	SUB	O
O	O	O	895	898	had	have	B-VP	VBD	O	0	ROOT	O
O	O	O	899	903	weak	weak	B-NP	JJ	O	8	NMOD	O
O	O	O	904	906	or	or	I-NP	CC	O	8	NMOD	O
O	O	O	907	909	no	no	I-NP	DT	O	8	NMOD	O
O	O	O	910	921	stimulatory	stimulatory	I-NP	JJ	O	8	NMOD	O
O	O	O	922	929	effects	effect	I-NP	NNS	O	3	OBJ	O
O	O	O	930	932	on	on	B-PP	IN	O	3	VMOD	O
O	O	O	933	936	HIV	HIV	B-NP	NN	O	11	NMOD	O
O	O	O	937	947	production	production	I-NP	NN	O	9	PMOD	O
O	O	O	948	950	by	by	B-PP	IN	O	11	NMOD	O
O	O	O	951	952	T	T	B-NP	NN	B-cell_line	16	NMOD	B-cell_line
O	O	O	952	953	-	-	I-NP	HYPH	I-cell_line	16	NMOD	I-cell_line
O	O	O	953	957	cell	cell	I-NP	NN	I-cell_line	16	NMOD	I-cell_line
O	O	O	958	963	lines	line	I-NP	NNS	I-cell_line	12	PMOD	I-cell_line
O	O	O	963	964	.	.	O	.	O	3	P	O

O	O	O	965	968	HIV	HIV	B-NP	NN	O	2	NMOD	O
O	O	O	969	979	production	production	I-NP	NN	O	11	SUB	O
O	O	O	980	982	by	by	B-PP	IN	O	2	NMOD	O
O	O	O	983	986	PMA	PMA	B-NP	NN	B-cell_line	10	NMOD	B-cell_line
O	O	O	986	987	-	-	O	HYPH	I-cell_line	10	P	I-cell_line
O	O	O	987	997	stimulated	stimulate	B-NP	VBN	I-cell_line	10	NMOD	I-cell_line
O	O	O	998	999	T	T	I-NP	NN	I-cell_line	10	NMOD	I-cell_line
O	O	O	999	1000	-	-	I-NP	HYPH	I-cell_line	10	NMOD	I-cell_line
O	O	O	1000	1004	cell	cell	I-NP	NN	I-cell_line	10	NMOD	I-cell_line
O	O	O	1005	1010	lines	line	I-NP	NNS	I-cell_line	3	PMOD	I-cell_line
O	O	O	1011	1014	was	be	B-VP	VBD	O	0	ROOT	O
O	O	O	1015	1024	inhibited	inhibit	I-VP	VBN	O	11	VC	O
O	O	O	1025	1027	by	by	B-PP	IN	O	12	VMOD	O
O	O	O	1028	1033	these	these	B-NP	DT	O	15	NMOD	O
O	O	O	1034	1043	retinoids	retinoid	I-NP	NNS	O	13	PMOD	O
O	O	O	1043	1044	.	.	O	.	O	11	P	O

O	O	O	1045	1048	The	The	B-NP	DT	O	5	NMOD	O
O	O	O	1049	1050	9	9	I-NP	CD	O	5	NMOD	O
O	O	O	1050	1051	-	-	I-NP	HYPH	O	5	NMOD	O
O	O	O	1051	1054	cis	cis	I-NP	NN	O	5	NMOD	O
O	O	O	1055	1057	RA	RA	I-NP	NN	O	6	SUB	O
O	O	O	1058	1061	was	be	B-VP	VBD	O	0	ROOT	O
O	O	O	1062	1071	generally	generally	B-ADJP	RB	O	9	AMOD	O
O	O	O	1072	1076	more	more	I-ADJP	RBR	O	9	AMOD	O
O	O	O	1077	1086	effective	effective	I-ADJP	JJ	O	6	PRD	O
O	O	O	1087	1091	than	than	B-PP	IN	O	9	AMOD	O
O	O	O	1092	1095	all	all	B-NP	RB	O	14	NMOD	O
O	O	O	1095	1096	-	-	I-NP	HYPH	O	14	NMOD	O
O	O	O	1096	1101	trans	trans	I-NP	JJ	O	14	NMOD	O
O	O	O	1102	1104	RA	RA	I-NP	NN	O	10	PMOD	O
O	O	O	1105	1107	in	in	B-PP	IN	O	6	VMOD	O
O	O	O	1108	1118	inhibiting	inhibit	B-VP	VBG	O	15	PMOD	O
O	O	O	1119	1122	HIV	HIV	B-NP	NN	O	18	NMOD	O
O	O	O	1123	1133	production	production	I-NP	NN	O	16	OBJ	O
O	O	O	1134	1137	and	and	B-PP	CC	O	6	VMOD	O
O	O	O	1138	1140	in	in	B-PP	IN	O	6	VMOD	O
O	O	O	1141	1152	combination	combination	B-NP	NN	O	20	PMOD	O
O	O	O	1153	1162	generally	generally	B-ADJP	RB	O	21	NMOD	O
O	O	O	1163	1167	more	more	I-ADJP	RBR	O	24	AMOD	O
O	O	O	1168	1177	effective	effective	I-ADJP	JJ	O	22	AMOD	O
O	O	O	1178	1182	than	than	B-PP	IN	O	22	AMOD	O
O	O	O	1183	1186	the	the	B-NP	DT	O	28	NMOD	O
O	O	O	1187	1193	single	single	I-NP	JJ	O	28	NMOD	O
O	O	O	1194	1200	agents	agent	I-NP	NNS	O	25	PMOD	O
O	O	O	1201	1206	alone	alone	B-ADVP	RB	O	28	NMOD	O
O	O	O	1206	1207	.	.	O	.	O	6	P	O

O	O	O	1208	1213	Human	Human	B-NP	JJ	B-protein	3	NMOD	B-protein
O	O	O	1214	1217	RAR	RAR	I-NP	NN	I-protein	3	NMOD	I-protein
O	O	O	1218	1223	alpha	alpha	I-NP	NN	I-protein	4	SUB	I-protein
O	O	O	1224	1227	was	be	B-VP	VBD	O	0	ROOT	O
O	O	O	1228	1237	expressed	express	I-VP	VBN	O	4	VC	O
O	O	O	1238	1240	in	in	B-PP	IN	O	5	VMOD	O
O	O	O	1241	1243	H9	H9	B-NP	NN	B-cell_line	14	NMOD	B-cell_line
O	O	O	1243	1244	,	,	I-NP	,	O	14	P	O
O	O	O	1245	1249	U937	U937	I-NP	NN	B-cell_line	14	NMOD	B-cell_line
O	O	O	1250	1253	and	and	I-NP	CC	O	14	NMOD	O
O	O	O	1254	1257	THP	THP	I-NP	NN	B-cell_line	14	NMOD	B-cell_line
O	O	O	1257	1258	-	-	B-NP	HYPH	I-cell_line	14	NMOD	I-cell_line
O	O	O	1258	1259	1	1	I-NP	CD	I-cell_line	14	NMOD	I-cell_line
O	O	O	1260	1265	cells	cell	I-NP	NNS	I-cell_line	6	PMOD	I-cell_line
O	O	O	1265	1266	,	,	O	,	O	18	P	O
O	O	O	1267	1270	but	but	O	CC	O	18	AMOD	O
O	O	O	1271	1277	almost	almost	B-ADJP	RB	O	18	AMOD	O
O	O	O	1278	1290	undetectable	undetectable	I-ADJP	JJ	O	4	PRD	O
O	O	O	1291	1293	in	in	B-PP	IN	O	18	AMOD	O
O	O	O	1294	1297	CEM	CEM	B-NP	NN	B-cell_line	21	NMOD	B-cell_line
O	O	O	1298	1303	cells	cell	I-NP	NNS	I-cell_line	19	PMOD	I-cell_line
O	O	O	1303	1304	.	.	O	.	O	4	P	O

O	O	O	1305	1310	Human	Human	B-NP	JJ	B-protein	3	NMOD	B-protein
T5	B-Protein	B-Protein	1311	1314	RXR	RXR	I-NP	NN	I-protein	3	NMOD	I-protein
T5	I-Protein	I-Protein	1315	1320	alpha	alpha	I-NP	NN	I-protein	4	SUB	I-protein
O	O	O	1321	1324	was	be	B-VP	VBD	O	0	ROOT	O
O	O	O	1325	1338	significantly	significantly	I-VP	RB	O	4	VMOD	O
O	O	O	1339	1348	expressed	express	I-VP	VBN	O	4	VC	O
O	O	O	1349	1351	in	in	B-PP	IN	O	6	VMOD	O
O	O	O	1352	1356	U937	U937	B-NP	NN	B-cell_line	13	NMOD	B-cell_line
O	O	O	1357	1360	and	and	I-NP	CC	O	13	NMOD	O
O	O	O	1361	1364	THP	THP	I-NP	NN	B-cell_line	13	NMOD	B-cell_line
O	O	O	1364	1365	-	-	B-NP	HYPH	I-cell_line	13	NMOD	I-cell_line
O	O	O	1365	1366	1	1	I-NP	CD	I-cell_line	13	NMOD	I-cell_line
O	O	O	1367	1372	cells	cell	I-NP	NNS	I-cell_line	7	PMOD	I-cell_line
O	O	O	1372	1373	,	,	O	,	O	6	P	O
O	O	O	1374	1380	weakly	weakly	B-VP	RB	O	16	VMOD	O
O	O	O	1381	1390	expressed	express	I-VP	VBN	O	6	VMOD	O
O	O	O	1391	1393	in	in	B-PP	IN	O	16	VMOD	O
O	O	O	1394	1396	H9	H9	B-NP	NN	B-cell_line	19	NMOD	B-cell_line
O	O	O	1397	1402	cells	cell	I-NP	NNS	I-cell_line	17	PMOD	I-cell_line
O	O	O	1403	1406	and	and	O	CC	O	16	VMOD	O
O	O	O	1407	1410	not	not	B-ADJP	RB	O	22	AMOD	O
O	O	O	1411	1421	detectable	detectable	I-ADJP	JJ	O	16	PRD	O
O	O	O	1422	1424	in	in	B-PP	IN	O	22	AMOD	O
O	O	O	1425	1428	CEM	CEM	B-NP	NN	B-cell_line	25	NMOD	B-cell_line
O	O	O	1429	1434	cells	cell	I-NP	NNS	I-cell_line	23	PMOD	I-cell_line
O	O	O	1434	1435	.	.	O	.	O	4	P	O

O	O	O	1436	1441	After	After	B-PP	IN	O	9	VMOD	O
O	O	O	1442	1453	stimulation	stimulation	B-NP	NN	O	1	PMOD	O
O	O	O	1454	1456	by	by	B-PP	IN	O	2	NMOD	O
O	O	O	1457	1460	PMA	PMA	B-NP	NN	O	3	PMOD	O
O	O	O	1460	1461	,	,	O	,	O	9	P	O
T6	B-Protein	B-Protein	1462	1465	RXR	RXR	B-NP	NN	B-protein	7	NMOD	B-protein
T6	I-Protein	I-Protein	1466	1471	alpha	alpha	I-NP	NN	I-protein	8	NMOD	I-protein
O	O	O	1472	1482	expression	expression	I-NP	NN	O	9	SUB	O
O	O	O	1483	1492	increased	increase	B-VP	VBD	O	0	ROOT	O
O	O	O	1493	1495	in	in	B-PP	IN	O	9	VMOD	O
O	O	O	1496	1498	H9	H9	B-NP	NN	B-cell_line	14	NMOD	B-cell_line
O	O	O	1499	1502	and	and	I-NP	CC	O	14	NMOD	O
O	O	O	1503	1507	U937	U937	I-NP	NN	B-cell_line	14	NMOD	B-cell_line
O	O	O	1508	1513	cells	cell	I-NP	NNS	I-cell_line	10	PMOD	I-cell_line
O	O	O	1514	1517	but	but	B-PP	CC	O	10	PMOD	O
O	O	O	1518	1521	not	not	B-PP	RB	O	17	PMOD	O
O	O	O	1522	1524	in	in	I-PP	IN	O	10	PMOD	O
O	O	O	1525	1528	CEM	CEM	B-NP	NN	B-cell_line	19	NMOD	B-cell_line
O	O	O	1529	1534	cells	cell	I-NP	NNS	I-cell_line	17	PMOD	I-cell_line
O	O	O	1534	1535	.	.	O	.	O	9	P	O

O	O	O	1536	1541	Human	Human	B-NP	JJ	B-protein	3	NMOD	B-protein
T7	B-Protein	B-Protein	1542	1545	RAR	RAR	I-NP	NN	I-protein	3	NMOD	I-protein
T7	I-Protein	I-Protein	1546	1551	alpha	alpha	I-NP	NN	I-protein	4	NMOD	I-protein
O	O	O	1552	1562	expression	expression	I-NP	NN	O	5	SUB	O
O	O	O	1563	1566	was	be	B-VP	VBD	O	0	ROOT	O
O	O	O	1567	1576	unchanged	unchanged	B-ADJP	JJ	O	5	PRD	O
O	O	O	1577	1579	in	in	B-PP	IN	O	6	AMOD	O
O	O	O	1580	1582	H9	H9	B-NP	NN	B-cell_line	11	NMOD	B-cell_line
O	O	O	1583	1586	and	and	I-NP	CC	O	11	NMOD	O
O	O	O	1587	1590	CEM	CEM	I-NP	NN	B-cell_line	11	NMOD	B-cell_line
O	O	O	1591	1596	cells	cell	I-NP	NNS	I-cell_line	7	PMOD	I-cell_line
O	O	O	1596	1597	,	,	O	,	O	5	P	O
O	O	O	1598	1601	and	and	O	CC	O	5	VMOD	O
O	O	O	1602	1610	elevated	elevate	B-VP	VBN	O	5	VMOD	O
O	O	O	1611	1613	in	in	B-PP	IN	O	14	VMOD	O
O	O	O	1614	1618	U937	U937	B-NP	NN	B-cell_line	17	NMOD	B-cell_line
O	O	O	1619	1624	cells	cell	I-NP	NNS	I-cell_line	15	PMOD	I-cell_line
O	O	O	1624	1625	,	,	O	,	O	14	P	O
O	O	O	1626	1631	after	after	B-PP	IN	O	14	VMOD	O
O	O	O	1632	1635	PMA	PMA	B-NP	NN	O	21	NMOD	O
O	O	O	1636	1647	stimulation	stimulation	I-NP	NN	O	19	PMOD	O
O	O	O	1647	1648	.	.	O	.	O	5	P	O

O	O	O	1649	1659	CONCLUSION	CONCLUSION	B-NP	NN	O	0	ROOT	O
O	O	O	1659	1660	:	:	O	:	O	1	P	O
O	O	O	1661	1664	The	The	B-NP	DT	O	4	NMOD	O
O	O	O	1665	1671	effect	effect	I-NP	NN	O	12	SUB	O
O	O	O	1672	1674	of	of	B-PP	IN	O	4	NMOD	O
O	O	O	1675	1677	RA	RA	B-NP	NN	O	5	PMOD	O
O	O	O	1678	1680	on	on	B-PP	IN	O	4	NMOD	O
T9	B-Entity	B-Entity	1681	1684	HIV	HIV	B-NP	NN	O	11	NMOD	O
T9	I-Entity	I-Entity	1684	1685	-	-	B-NP	HYPH	O	11	NMOD	O
T9	I-Entity	I-Entity	1685	1686	1	1	I-NP	CD	O	11	NMOD	O
O	O	O	1687	1697	expression	expression	I-NP	NN	O	7	PMOD	O
O	O	O	1698	1701	was	be	B-VP	VBD	O	1	NMOD	O
O	O	O	1702	1706	cell	cell	B-NP	NN	O	12	PRD	O
O	O	O	1706	1707	-	-	B-NP	HYPH	O	13	NMOD	O
O	O	O	1707	1711	type	type	I-NP	NN	O	14	PMOD	O
O	O	O	1711	1712	-	-	O	HYPH	O	15	P	O
O	O	O	1712	1721	dependent	dependent	B-ADJP	JJ	O	15	AMOD	O
O	O	O	1722	1725	and	and	O	CC	O	15	VMOD	O
O	O	O	1726	1735	partially	partially	B-VP	RB	O	20	VMOD	O
O	O	O	1736	1746	correlated	correlate	I-VP	VBN	O	18	DEP	O
O	O	O	1747	1751	with	with	B-PP	IN	O	20	VMOD	O
O	O	O	1752	1760	cellular	cellular	B-NP	JJ	O	23	NMOD	O
O	O	O	1761	1771	expression	expression	I-NP	NN	O	21	PMOD	O
O	O	O	1772	1774	of	of	B-PP	IN	O	23	NMOD	O
O	O	O	1775	1779	RARs	RAR	B-NP	NNS	B-protein	24	PMOD	B-protein
O	O	O	1779	1780	.	.	O	.	O	12	P	O

O	O	O	1781	1791	Endogenous	Endogenous	B-NP	JJ	O	5	NMOD	O
O	O	O	1792	1794	or	or	I-NP	CC	O	5	NMOD	O
O	O	O	1795	1806	exogenously	exogenously	I-NP	RB	O	4	NMOD	O
O	O	O	1807	1819	administered	administer	I-NP	VBN	O	5	NMOD	O
O	O	O	1820	1822	RA	RA	I-NP	NN	O	6	SUB	O
O	O	O	1823	1826	may	may	B-VP	MD	O	0	ROOT	O
O	O	O	1827	1831	have	have	I-VP	VB	O	6	VC	O
O	O	O	1832	1833	a	a	B-NP	DT	O	10	NMOD	O
O	O	O	1834	1845	significant	significant	I-NP	JJ	O	10	NMOD	O
O	O	O	1846	1850	role	role	I-NP	NN	O	7	OBJ	O
O	O	O	1851	1853	in	in	B-PP	IN	O	7	VMOD	O
O	O	O	1854	1857	HIV	HIV	B-NP	NN	O	13	NMOD	O
O	O	O	1858	1868	regulation	regulation	I-NP	NN	O	11	PMOD	O
O	O	O	1868	1869	.	.	O	.	O	6	P	O
